Institution · Phoenix Nest (United States)

Most cited papers from Phoenix Nest (United States)

Phoenix Nest (United States)

What are the most cited papers from Phoenix Nest (United States)?

The most cited paper from Phoenix Nest (United States) is "Multifaceted roles of ultra-rare and rare disease patients/parents in drug discovery" (Jill Wood, Lori Sames, Allison T. Moore et al., 2013), with 40 citations. Next come "Industrializing rare disease therapy discovery and development" (30) and "Collaboration for rare disease drug discovery research" (28).

Published TypeFieldAccess

Showing 26 of 26 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Multifaceted roles of ultra-rare and rare disease patients/parents in drug discovery Jill Wood, Lori Sames, Allison T. Moore et al. · Drug Discovery Today	19 Aug 2013	40
2	Industrializing rare disease therapy discovery and development Sean Ekins · Nature Biotechnology Open access	Feb 2017	30
3	Collaboration for rare disease drug discovery research Nadia K. Litterman, Michele Rhee, David C. Swinney et al. · F1000Research Open access	31 Oct 2014	28
4	Enabling Anyone to Translate Clinically Relevant Ideas to Therapies Sean Ekins, Natalie Diaz, Julia A. Chung et al. · Pharmaceutical Research	12 Sep 2016	24
5	Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-N-Acetylglucosamine-6-Sulfatase in Neonatal Mice Rui Wang, Derek R. Moen, Chelsee Sauni et al. · Molecular Pharmaceutics Open access	15 Dec 2020	17
6	Genetically Corrected iPSC-Derived Neural Stem Cell Grafts Deliver Enzyme Replacement to Affect CNS Disease in Sanfilippo B Mice Don Clarke, Yewande Pearse, Shih‐hsin Kan et al. · Molecular Therapy — Methods & Clinical Development Open access	23 Jul 2018	16
7	Evaluation of artificial signal peptides for secretion of two lysosomal enzymes in CHO cells Kai-Wen Cheng, Rui Wang, George A. Lopez et al. · Biochemical Journal Open access	25 May 2021	13
8	Histological characterization of retinal degeneration in mucopolysaccharidosis type IIIC Jessica E. Ludwig, Onkar B. Sawant, Jill Wood et al. · Experimental Eye Research Open access	27 Feb 2023	10
9	Incentives for Starting Small Companies Focused on Rare and Neglected Diseases Sean Ekins, Jill Wood · Pharmaceutical Research Open access	14 Dec 2015	8
10	Shedding Light on Synergistic Chemical Genetic Connections with Machine Learning Sean Ekins, Jair L. Siqueira-Neto · Cell Systems Open access	Dec 2015	4
11	Chaperone therapy for mucopolysaccharidosis type IIIC Alexey V. Pshezhetsky, Xuefang Pan, Rachel Heon‐Roberts et al. · Molecular Genetics and Metabolism	Feb 2018	2
12	Recombinant human alpha-N-acetylglucosamine-6-sulfatase delivered to Sanfilippo D mice with repeated intracerebroventricular injections corrects CNS pathology Grant L. Austin, Rui Wang, Steven Q. Le et al. · PLoS ONE Open access	25 Jul 2025	1
13	iPSC derived neurons of mucopolysaccharidosis III patients show pronounced synaptic defects Travis Mooree, Poulomee Bose, Jill Wood et al. · Molecular Genetics and Metabolism	Feb 2022	1
14	Pilot enzyme replacement therapy with recombinant human glucosamine (N-acetyl)-6-sulfatase in mucopolysaccharidosis type IIID mouse model Chelsee Sauni, Feng Wang, Shih‐hsin Kan et al. · Molecular Genetics and Metabolism	Feb 2018	1
15	Scale-up processing of recombinant human glucosamine (n-acetyl)-6-sulfatase for the treatment of mucopolysaccharidosis type IIID Derek R. Moen, Mengqing Chen, Shih‐hsin Kan et al. · Molecular Genetics and Metabolism	2017	1
16	Expanding the clinical spectrum of sanfilippo syndrome type D: Detailed phenotyping from a nine-participant cohort Andres Morales Corado, Candace Cameron, Arang Kim et al. · Molecular Genetics and Metabolism	May 2026	0
17	Synthetic analogue of adrenocorticotropic hormone, ACTH (4-7) PGP delays neurological manifestations in diseases of mucopolysaccharidosis III spectrum by reducing neuroinflammation and rescuing neurotransmission, synaptogenesis, and axonal demyelination Travis I. Moore et al. · bioRxiv (Cold Spring Harbor Laboratory) Preprint	24 Feb 2026	0
18	Insulin Medication Trends in Diabetes Management: A Comprehensive USDDS Database Analysis Okelue Edwards Okobi, Olutayo Olaide Olasupo, Akinbanji R Afolabi et al. · Journal of Advances in Medicine and Medical Research Open access	31 Jul 2024	0
19	Uptake and Lysosomal Delivery of Recombinant Human Alpha‐ N ‐Acetylglucosamine‐6‐Sulfatase to Mucopolysaccharidosis IIID Fibroblasts Derek R. Moen, Daniel Wang, Xiaoyi Zhang et al. · The FASEB Journal	Apr 2016	0
20	A natural history study of Sanfilippo syndrome type D (MPS type IIID) Heather Lau, Pramod Kumar Mistry, Jill Wood et al. · Molecular Genetics and Metabolism	Feb 2022	0
21	Enzyme replacement therapy (ERT) for MPS IIID Tsui‐Fen Chou, Rui Wang, Steven Q. Le et al. · Molecular Genetics and Metabolism	Feb 2022	0
22	Histological Characterization of Photoreceptor Degeneration in a Mouse Model of Mucopolysaccharidosis Type IIIC Onkar Sawant, Jill Wood, Srikanth Singamsetty et al. · Investigative Ophthalmology & Visual Science Open access	10 Jun 2020	0
23	Enzyme replacement therapy for mucopolysaccharidosis type IIID Tsui‐Fen Chou, Derek R. Moen, Chelsee Sauni et al. · Molecular Genetics and Metabolism	Feb 2019	0
24	How our approach for Sanfilippo syndrome could be a prototype for industrializing rare disease drug discovery and development Jill Wood, Sean Ekins · Molecular Genetics and Metabolism	2017	0
25	Phoenix Nest: Starting a small company focused on Sanfilippo syndrome Sean Ekins, Jill Wood · Molecular Genetics and Metabolism Open access	28 Jan 2015	0
26	Virtual collaborations for developing Sanfilippo syndrome treatments on a shoestring Sean Ekins, Derek R. Moen, Jill Wood · Molecular Genetics and Metabolism	Feb 2016	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.